Combined Stereotactic Body Radiotherapy and Checkpoint Inhibition in Unresectable Hepatocellular Carcinoma: A Potential Synergistic Treatment Strategy

Combined Stereotactic Body Radiotherapy and Checkpoint Inhibition in Unresectable Hepatocellular Carcinoma: A Potential Synergistic Treatment Strategy

Background: Current treatments of unresectable hepatocellular carcinoma (HCC) are trans-arterial chemo-embolization (TACE), stereotactic body radiotherapy (SBRT), and targeted therapy. However, these treatments are limited in efficacy and safety for patients with large tumor sizes. Here, we report a...

Full description

Bibliographic Details
Main Authors: Chi-Leung Chiang, Albert C. Y. Chan, Keith W. H. Chiu, Feng-Ming (Spring) Kong
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-11-01
Series:Frontiers in Oncology
Subjects:
stereotactic radiation therapy
stereotactic ablative radiation therapy
checkpoint inhibitor
immunotherapy
hepatocellular carcinoma
HCC
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01157/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.01157/full

Similar Items